UEMS Medical Specialty
Geriatrics & Longevity Medicine — Page 2
Dossiers covering senolytic compounds, NAD⁺ precursor supplementation, cellular senescence, and evidence-based longevity medicine formulations.
26
dossiers
Cellular Longevity & Senolytics
Synergistic Modulation of Cellular Senescence Biomarkers by Target-Specific Nutraceutical Matrices
Developing a nutraceutical matrix that precisely modulates senescence-related biomarkers requires integrating senolytic activity, SASP suppression, and mitochondrial restoration within a single formulation while ensuring in vitro reproducibility and scalability.
Cellular Longevity & Senolytics
Comparative Pharmacokinetics and Cellular Bioaccessibility of Senolytic Agents: Impact of Polymeric-Matrix Encapsulation
Orally administered senolytic compounds often suffer from poor pharmacokinetics, including low and variable bioavailability, rapid metabolism, pH-dependent dissolution, and limited cellular bioaccessibility.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.